Eurofarma announces finalist companies for the Euro Innovation Award
Published in: July 3, 2020
and updated in: November 4, 2021
Listen to the text
Stop the audio
São Paulo, July 2020 – Throughout Brazil, more than 15,000 physicians voted and helped choose the 11 finalist projects for the Euro Innovation in Health Award, the largest award aimed at recognizing innovative healthcare projects with a high social impact in the country. In this final stage, physicians will have until August 4 to choose the top winner.
Meet the 11 finalists:
The purpose of the award is to recognize and offer incentives in the search for solutions in products, services and innovative actions to improve the quality of life and well-being of Brazilians. The Euro Innovation in Health award will distribute a total of € 1,000,000.00 (one million euros) in prize money, with 10 projects receiving the equivalent to € 50,000.00 (fifty thousand euros) in Brazilian reais and a top winner earning the equivalent to € 500,000.00 (five hundred thousand euros) in Brazilian reais.
To learn more and vote on the projects, go to www.premioeuro.com.br.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
EUROFARMA ON SOCIAL MEDIA
www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab
Meet the 11 finalists:
| Marcos Rodrigues Furtado de Mendonça | Médicos do bem | Juiz de Fora, MG |
| Diego Ariel de Lima | Alternative to the orthopedic traction table: a prototype applicable to medical practice and teaching | Mossoró, RN |
| Patrícia Moreno Grangeiro | Remo meu Rumo Institute - Rowing is much more than a sport | São Paulo, SP |
| Celso Amodeo | Cardiometer | São Paulo, SP |
| Edmar Maciel Lima Jr. | Tilapia Skin: A new biomaterial for treating burns, wounds, gynecological surgeries and regenerative medicine | Fortaleza, CE |
| Francisco Irochima Pinheiro | New mobile device to combat keratoconus blindness (Topograph Smartphone System) | Natal, RN |
| Gabriel Fernando Todeschi Variane | Protecting brains & saving futures - PBSF | São Paulo, SP |
| Nucelio Luiz de Barros Moreira Lemos | Laparoscopic implantation of neuromodulators in the rehabilitation of people with spinal cord injury | São Paulo, SP |
| Ana Mayra Andrade de Oliveira | Study on childhood obesity and its comorbidities: a path to better health | Feira de Santana, BA |
| Viviane Sampaio Boaventura de Oliveira | Mitigating the impact of chronic post-chikungunya arthralgia | Salvador, BA |
| Alberto da Silva Dias Filho | EndoNews | Goiânia, GO |
The purpose of the award is to recognize and offer incentives in the search for solutions in products, services and innovative actions to improve the quality of life and well-being of Brazilians. The Euro Innovation in Health award will distribute a total of € 1,000,000.00 (one million euros) in prize money, with 10 projects receiving the equivalent to € 50,000.00 (fifty thousand euros) in Brazilian reais and a top winner earning the equivalent to € 500,000.00 (five hundred thousand euros) in Brazilian reais.
To learn more and vote on the projects, go to www.premioeuro.com.br.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
EUROFARMA ON SOCIAL MEDIA
www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab